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Abstract
Atherosclerotic plaque growth is characterised by chronic inflammation that
promotes accumulation of cellular debris and extracellular fat in the inner
artery wall. This material is highly thrombogenic, and plaque rupture can
lead to the formation of blood clots that occlude major arteries and cause
myocardial infarction or stroke. In advanced plaques, vascular smooth mus-
cle cells (SMCs) migrate from deeper in the artery wall to synthesise a cap
of fibrous tissue that stabilises the plaque and sequesters the thrombogenic
plaque content from the bloodstream. The fibrous cap provides crucial pro-
tection against the clinical consequences of atherosclerosis, but the mecha-
nisms of cap formation are poorly understood. In particular, it is unclear
why certain plaques become stable and robust while others become fragile
and vulnerable to rupture.
We develop a multiphase model with non-standard boundary conditions
to investigate early fibrous cap formation in the atherosclerotic plaque. The
model is parameterised using a range of in vitro and in vivo data, and in-
cludes highly nonlinear mechanisms of SMC proliferation and migration in
response to an endothelium-derived chemical signal. We demonstrate that
the model SMC population naturally evolves towards a steady-state, and
predict a rate of cap formation and a final plaque SMC content consistent
with experimental observations in mice. Parameter sensitivity simulations
show that SMC proliferation makes a limited contribution to cap formation,
and highlight that stable cap formation relies on a critical balance between
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SMC recruitment to the plaque, SMC migration within the plaque and SMC
loss by apoptosis. The model represents the first detailed in silico study of
fibrous cap formation in atherosclerosis, and establishes a multiphase mod-
elling framework that can be readily extended to investigate many other
aspects of plaque development.
Keywords: Vascular disease, Multiphase, Smooth muscle cell,
Platelet-derived growth factor
1. Introduction
Atherosclerosis is an inflammatory disease characterised by the formation
of fatty lesions in the inner lining of the artery. These lesions develop slowly
over many years and can eventually rupture to cause myocardial infarction
or stroke (Hansson and Libby, 2006). Vascular smooth muscle cells (SMCs)
contribute to the prevention of plaque rupture by synthesising a cap of fi-
brous tissue that stabilises dangerous plaques (Vassiliadis et al., 2013). A
complete understanding of how SMCs develop and then maintain the fibrous
cap is therefore crucial, but experimental investigations are hampered by the
extremely slow nature of in vivo cap formation. Mathematical modelling
provides an attractive alternative to laboratory studies, and in this paper we
develop a model to investigate the SMC dynamics that lead to formation of
the protective fibrous cap.
The arterial wall consists of a series of distinct tissue layers (Figure 1).
A thin sheet of endothelial cells (the endothelium) makes up the innermost
layer of the wall. These cells are directly exposed to the flow of blood in
the vessel lumen. Immediately beneath the endothelium lies a narrow tis-
sue layer called the intima, which is separated from the underlying media
by a dense tissue membrane known as the internal elastic lamina (IEL). Be-
yond the media there is a further layer known as the adventitia. Growth of
an atherosclerotic plaque is triggered when blood-borne low density lipopro-
teins (LDL) penetrate the vessel endothelium, become oxidised or modified in
other ways and accumulate in the intima. The subsequent immune response
causes monocytes to exit the bloodstream, differentiate into macrophages
and consume the LDL to become foam cells. Death of these lipid-laden
macrophages within the vessel wall leads to the deposition of cellular debris
and extracellular fat. This stimulates further macrophage recruitment and
chronic inflammation typically ensues. The associated accumulation of ma-
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terial (some of which may eventually become necrotic) distends the intima,
leading to mechanical disruption and tissue remodelling of the artery (Ross,
1999).
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Figure 1: Cross-section of a healthy artery showing the layered structure of the inner
artery wall (layer widths not to scale, and adventitia not shown). Atherosclerotic plaques
are initiated by infiltration of lipoproteins and immune cells across the endothelium into
the intima from the bloodstream in the lumen. In advanced stage plaques, SMCs from
the media are activated and migrate through the internal elastic lamina into the intima.
In healthy arteries, most vascular SMCs are in a quiescent (contractile)
state within the medial layer of the vessel wall. During atherosclerotic plaque
formation, however, these cells are stimulated to adopt a synthetic phenotype
and migrate through the IEL to remodel the extracellular matrix (ECM) in
the intima (Libby and Ridker, 2006). Faggiotto and Ross (1984) have sug-
gested that disruption of the endothelium by foam cell accumulation may
prompt the activation of SMCs, but the precise mechanisms that underlie
the initiation of this response remain unclear. The resulting deposition of a
cap of fibrous tissue between the endothelium and the lipid-rich plaque core
suggests a key role for SMC chemoattractants in the process of vessel wall
remodelling. A variety of cytokines and growth factors have been identified
in advanced plaques, but platelet-derived growth factor (PDGF) — a potent
stimulator of both SMC migration and mitosis — is likely to be the domi-
nant chemoattractant in fibrous cap formation (Rutherford et al., 1997; Sano
et al., 2001). Indeed, PDGF is known to be expressed by a variery of plaque
cells including both endothelial cells and platelets from the bloodstream that
adhere to sites of vascular injury (Kozaki et al., 2002). Figure 2 summarises
the cap formation process in a schematic diagram.
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Figure 2: Schematic diagram of the key processes in fibrous cap formation. The accu-
mulation of lipoproteins and immune cells in early atherosclerotic plaques (not shown)
causes expansion of the intima and disruption of the endothelium. Endothelial cells and
adherent platelets at sites of endothelial disruption release platelet-derived growth factor
(PDGF), which creates a PDGF gradient across the artery wall. Vascular SMCs, which
usually reside in a contractile state in the medial layer, respond chemotactically to the
PDGF gradient and migrate into the intima through the internal elastic lamina. These
so-called synthetic SMCs remodel the ECM in the intima and deposit a cap of collagenous
tissue adjacent to the endothelium. This tissue cap provides a dense barrier that prevents
the release of thrombogenic plaque material into the bloodstream.
The formation of an atherosclerotic plaque is typically preceded by a
gradual expansion of the intima known as diffuse intimal thickening. This
phenomenon, which begins in infancy and continues throughout life, involves
the deposition of a matrix of elastin and proteoglycans by a small population
of non-proliferative SMCs (Nakashima et al., 2008). During plaque develop-
ment, the existing intimal tissue undergoes substantial changes: migrating
media-derived SMCs degrade the existing ECM components and deposit a
new matrix composed primarily of fibrillar collagens (Adiguzel et al., 2009).
Transforming growth factor (TGF)-β, an anti-inflammatory and pro-fibrotic
cytokine that is expressed by a wide variety of plaque cells (Toma and Mc-
Caffrey, 2012), is an important mediator of this remodelling process (Lutgens
et al., 2002).
The fibrous collagen cap synthesised by SMCs provides a dense tissue
barrier that sequesters thrombogenic plaque material from the bloodstream
and contributes to the prevention of plaque rupture. The ability to generate,
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and then maintain, a cap of sufficient thickness is therefore a key determinant
of long-term disease prognosis. The exact mechanisms that underlie fibrous
cap development are not well understood, and it remains unclear why certain
fibrous caps remain stable and robust while others are fragile and vulnera-
ble to rupture (Virmani et al., 2000; Hansson et al., 2015). It is frequently
posited in the literature that an established fibrous cap can be eroded over
time (Lusis, 2000; Libby, 2002). A number of factors have been linked to this
phenomenon — amplified matrix metalloproteinase (MMP) production due
to excessive inflammatory cell recruitment, for example — but a complete
picture has yet to emerge (Newby and Zaltsman, 1999). In this work, we
investigate potential sources of plaque instability by developing a mathemat-
ical model to study the cellular and biochemical mechanisms that contribute
to fibrous cap synthesis. By focussing on the initial SMC response, we ad-
dress the fundamental question of whether certain atherosclerotic plaques
may be pre-disposed to the formation of a thin fibrous cap. This founda-
tional study provides a framework that can ultimately be extended to more
detailed investigations of atherosclerotic plaque development.
A variety of mathematical models have been developed to investigate
SMC migration and neo-intima formation in the vessel wall. An area of par-
ticular research interest is arterial restenosis, which can occur in response
to surgical procedures such as angioplasty and stenting. These procedures
are used to widen arteries constricted by plaque growth, but they can also
damage the endothelium and elicit a response from SMCs that leads to neo-
intima formation and recurrence of the luminal narrowing. The SMC be-
haviour that leads to this restenosis has been modelled using both discrete
(Boyle et al., 2011; Tahir et al., 2015) and continuum (Lally and Prender-
gast, 2006) approaches. Modelling has also been performed to study the
response of vascular SMCs to other surgical interventions, including vein
grafting (Budu-Grajdeanu et al., 2008; Garbey and Berceli, 2013) and the
implant of blood filters (Nicolas et al., 2015). Activation of vascular SMCs to
repair the vessel wall after endothelial injury has several similarities with der-
mal wound healing, which has been widely studied in the modelling literature
(Machado et al., 2010; Menon et al., 2012; Bowden et al., 2014). The equiv-
alent cell to the SMC in the wound healing context is the fibroblast, which
is recruited to the wound site by growth factors such as PDGF to synthe-
sise new ECM and stimulate wound contraction. The chemotactic response
of fibroblasts to PDGF during wound healing has been modelled in detail
by Haugh (2006), while a host of approaches have been used to study the
5
re-generation of dermal fibrous tissue by this motile cell population (Olsen
et al., 1995; Dale et al., 1997; Dallon and Sherratt, 1998; McDougall et al.,
2006; Murphy et al., 2011).
Mathematical modelling of the cellular activity in the vessel wall during
atherosclerosis is an area of growing research interest (see Parton et al. (2016)
for a comprehensive review). To date, however, the vast majority of published
models have investigated the actions of monocytes/macrophages in disease
initiation (El Khatib et al., 2007; Pappalardo et al., 2008; Cohen et al., 2014;
Chalmers et al., 2015; Bhui and Hayenga, 2017) and only a handful have
explicitly considered the role of SMCs in plaque progression. This possibility
was first discussed in the work of McKay et al. (2004), who proposed a simple
reaction-diffusion framework for plaque formation that included both SMC
migration and collagen remodelling. Cilla et al. (2014) included differenti-
ation of SMCs from a contractile to a synthetic phenotype in their coupled
model of blood flow and plaque growth. As with a number of other studies
(Ibragimov et al., 2005; Poston and Poston, 2007), however, the simplified
representation of SMC behaviour in this model fails to adequately describe
the process of cap formation. Fok (2012) used a moving boundary model
to investigate mechanisms of intimal thickening. This model included SMC
migration and proliferation in response to an endothelium-derived source of
PDGF, and is, to the best of our knowledge, the only existing approach that
shares similarities with the current work.
Previous work in our group (Ougrinovskaia, 2010) has seen the develop-
ment of a detailed reaction-diffusion model describing the spatio-temporal
evolution of the key cytokines and tissue constituents involved in long-term
plaque development. This model successfully predicted morphological as-
pects of plaques and led to many interesting outcomes, but certain features
of the approach remain unsatisfactory. A particular shortcoming of the model
is that it fails to account for volume filling or exclusion as material accumu-
lates in the intima over time. This is an important consideration, and we
address this in the current study by modelling fibrous cap formation in the
intima using a multiphase approach. Multiphase models, which provide a
natural framework to study heterogeneous tissues, have been widely applied
in contexts such as cancer (Preziosi and Tosin, 2009; Hubbard and Byrne,
2013) and tissue engineering (Lemon et al., 2006; Pearson et al., 2014). The
approach has also recently been applied in atherosclerosis to study the influ-
ence of the plasma lipid profile on plaque growth and regression (Hao and
Friedman, 2014; Friedman and Hao, 2015). SMC migration and ECM re-
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modelling were included in this study, but formation of the fibrous cap was
not explicitly investigated.
The model of Hao and Friedman (2014) uses fifteen different variables
to represent various chemical, cellular and tissue components implicated in
atherosclerotic plaque formation. In the current study, we adopt an alterna-
tive approach and focus on the interaction between only two key variables.
The benefit of this approach is that we can perform a detailed investigation of
the cell behaviour and obtain insight that could not be easily achieved using
larger models with generalist, non-specific assumptions. Our model consid-
ers only the early SMC response to injury-induced chemical signalling from
the endothelium and neglects the immune response that drives initial lesion
growth. We do not explicitly consider SMC remodelling of the ECM or, in-
deed, fibrous cap synthesis — instead we investigate the mechanisms of SMC
migration and proliferation in the plaque and assess the likely implications
for cap stability.
Full details of the modelling assumptions and the model parameterisation
are introduced in the next section. This is followed by simulation results and
a parameter sensitivity study. We conclude with a discussion of the outcomes
of this work in the context of both atherosclerosis modelling and biomedical
atherosclerosis research.
2. Model Formulation and Parameterisation
2.1. Model Description
We model this system with a multiphase approach on a one-dimensional
Cartesian domain x ∈ [0, L]. This region, which ranges from the endothe-
lium (x = 0) to the SMC-bearing media (x = L), is assumed to represent a
cross-section of diseased intimal tissue far from the edges of the plaque. The
composition of the intima evolves in a complex manner during atheroscle-
rosis progression, and the relative quantities of constituents such as lipids,
monocytes, foam cells, SMCs, interstitial fluid and ECM proteins change over
time. Although each of these elements may ultimately have some role to play
in cap formation, the complexity of a multiphase model that comprises all
components individually is less likely to provide mechanistic insights than a
simpler model. We therefore propose a model that involves only two phases:
(1) SMCs and (2) all other cells and tissues (i.e. a non-SMC phase), with
volume fractions denoted by m(x, t) and w(x, t), respectively. We do not ex-
plicitly consider any remodelling of the ECM within the vessel wall; rather,
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we assume that, over time, the distribution of deposited matrix — and thus
any fibrous cap — will evolve to broadly reflect the underlying SMC pro-
file. The variable m(x, t) should, therefore, be defined more specifically as
the volume fraction of matrix-synthesising SMCs. This is a key assumption.
Vascular SMCs are known to be extremely plastic and capable of demon-
strating a broad range of behaviours (Owens et al., 2004; Majesky, 2016),
but we will consider only this particular phenotype.
We define a number of additional variables before we generate the model
equations. The velocities of the SMC and non-SMC phases are vm(x, t)
and vw(x, t), and the corresponding stresses experienced by these phases are
τm(x, t) and τw(x, t). We also introduce p(x, t) to represent the interstitial
fluid pressure. The process of medial SMC activation and subsequent fibrous
cap formation relies heavily on a range of chemical cues, with PDGF believed
to perform a crucial role as a potent SMC chemoattractant (Ross et al.,
1990; Newby and Zaltsman, 1999). Therefore, in addition to the volume-
occupying phases within the intima, we include a profile of diffusible PDGF.
This is assumed to be present only in the non-SMC phase, with concentration
c(x, t).
Mass Balance Equations
Given that biological tissues are primarily composed of water, we assume
that both the SMC and non-SMC phases have the same constant density.
Applying mass balances to each phase, we obtain:
∂m
∂t
+
∂
∂x
(vmm) = Sm (c,m,w) , (1)
∂w
∂t
+
∂
∂x
(vww) = −Sm (c,m,w) , (2)
where Sm denotes the net rate of matrix-producing SMC proliferation or loss
within the intima, which may depend on c, m and w. Note that we have also
assumed that there is no local source or sink of material: proliferating cells
are assumed to grow by absorbing material (e.g. water) from the surrounding
tissue, while cells that die (or simply cease ECM synthesis) return to the bulk
tissue phase. As suggested by the definitions of m and w, there is a no-voids
condition:
m+ w = 1, (3)
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which reflects an underlying assumption that the intimal tissue within the
vessel wall is both continuous and incompressible.
The characteristic timescale of chemical diffusion of PDGF is likely to be
significantly shorter than that of SMC migration. Therefore, we neglect the
role of advective transport within the non-SMC phase, and assume that the
concentration of PDGF in the intima is at steady-state and given by:
Dc
∂
∂x
(
w
∂c
∂x
)
= ηcmwc+ βcwc, (4)
where ηc and βc represent the SMC uptake and chemical decay rates, re-
spectively (Astanin and Preziosi, 2008). Note that the reaction terms both
include a dependence on w under the assumption that neither uptake nor
decay occurs in the absence of non-SMC material. This is because the model
assumes that PDGF is only present in the non-SMC fraction. The diffusion
coefficient of PDGF is Dc and w modulates diffusive transport under the
assumption that limited transport occurs when the SMC volume fraction is
high or, equivalently, w is low.
There is no source term for PDGF in the above equation. PDGF is
introduced into the domain through an appropriate boundary condition at
the lumen. We postpone the detailed discussion of boundary conditions until
later, but we emphasise here the crucial role that boundary conditions will
play in capturing many of the key aspects of cap formation.
Momentum Balance Equations and Constitutive Assumptions
In the absence of external body forces, and assuming that inertial ef-
fects are negligible, the momentum equations reduce to a balance between
intraphase and interphase forces for the SMC and non-SMC phases, respec-
tively:
∂
∂x
(τmm) = −Fmw, (5)
∂
∂x
(τww) = Fmw. (6)
The interphase force exerted by the non-SMC phase on the SMC phase is
denoted by Fmw (note that the SMCs exert an equal and opposite force on the
other phase), and we assume an expression of the following form (Breward
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et al., 2002; Byrne and Owen, 2004):
Fmw = −p ∂w
∂x
+ kmw (vw − vm) . (7)
The first term on the right hand side arises from the volumetric averaging
process that underpins the multiphase approach (Drew and Segel, 1971). It
contributes a force due to the distribution of pressure at the interface between
the phases. On the microscale, the force experienced by an element of one
phase due to the other phase will increase with increasing interfacial contact
between the phases. The form of this term reflects the overall macroscopic
manifestation of this microscale phenomenon (Lemon et al., 2006). The
second term in equation (7) represents a simple viscous drag between the
phases that is characterised by the drag coefficient k.
For the respective stress terms τm and τw in equations (5) and (6) above,
we propose the following models (Breward et al., 2002; Byrne and Owen,
2004):
τm = −p− Λ (c) , (8)
τw = −p, (9)
where, for simplicity, we have neglected viscous effects within either phase.
The non-SMC phase comprises a mixture of cells and tissues that, in reality,
is likely to have some influence on SMC migration within the intima. We will
assume here that it is an inert isotropic fluid in order to focus primarily on
the role played by PDGF in fibrous cap formation. The second term on the
right hand side of equation (8) reflects an assumption that SMC behaviour is
more complex than that of the non-SMC phase, with cell motility assumed
to be influenced by the local PDGF concentration. We define the function
Λ (c) to be:
Λ (c) =
χ
1 + (κc)n
, (10)
where χ, κ and n are positive parameters (Byrne and Owen, 2004). This
model assumes that SMC phase pressure decreases with increasing PDGF
concentration. This assumption allows movement up the chemical gradient
(i.e. chemotaxis) to be represented as a mechanism of stress relief in the
SMC phase.
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Model Simplification
In this section, we use the above definitions to derive a reduced nonlinear
system of PDEs that describes early fibrous cap formation in the intima.
The model comprises a single parabolic equation for the SMC volume frac-
tion m(x, t) coupled to an elliptic reaction-diffusion equation for the PDGF
concentration c(x, t). We consider the boundary and initial conditions re-
quired to close the system in the next section. The model simplification is
similar to that reported in Byrne and Owen (2004), but we include the full
details for clarity.
We use the no-voids condition of equation (3) to replace all occurrences
of the non-SMC phase volume fraction w(x, t) by its equivalent expression
1 −m(x, t). Under this assumption, the sum of the mass balance equations
(1) and (2) reduces to:
∂
∂x
(vmm+ vw (1−m)) = 0. (11)
Integrating this equation, and applying a zero-flux condition for SMCs at the
lumen (i.e. vm = vw = 0 at x = 0), the velocity vw of the non-SMC phase can
be expressed in terms of the velocity vm of the SMC phase in the following
way:
vw = −vm
(
m
1−m
)
. (12)
Using the definitions (8) and (9), the momentum balance equations (5) and
(6) can be added to give the relationship:
∂
∂x
(τmm+ τw (1−m)) = − ∂
∂x
(p+mΛ) = 0. (13)
Note that there is no requirement to perform the integration here. We will
use this expression in its current form to eliminate the tissue pressure p(x, t)
from the equations. For now, we proceed by substituting the expressions (7)
and (9) into equation (6) for the non-SMC phase momentum balance to find:
− ∂
∂x
(p (1−m)) = −p ∂
∂x
(1−m) + km (1−m) (vw − vm) . (14)
By expanding the left hand side and cancelling terms, equation (14) can be
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reduced to:
− ∂p
∂x
= km (vw − vm) . (15)
Now, using equations (13) and (12), respectively, we can eliminate all other
variables in equation (15) and express vm simply in terms of m and c:
vm = vw − 1
km
∂
∂x
(mΛ) = −(1−m)
km
∂
∂x
(mΛ) . (16)
This expression for the cell phase velocity can then be substituted back into
equation (1), to derive the final mass balance relationship for SMCs in the
intima:
∂m
∂t
=
1
k
∂
∂x
[
(1−m) ∂
∂x
(mΛ (c))
]
+ Sm (c,m) . (17)
For consistency, we may also remove all references to w(x, t) in equation
(4), and our simplified model then comprises equation (17) along with the
following expression for the PDGF concentration:
Dc
∂
∂x
(
(1−m) ∂c
∂x
)
= ηccm (1−m) + βcc (1−m) . (18)
Boundary and Initial Conditions
Before discussing the boundary conditions for our system, it is instructive
to expand the flux term in equation (17) and separate it into explicit diffusive
and chemotactic contributions. We use this format to define an appropriate
boundary condition for SMC entry into the intima from the media. Recalling
the definition of the extra pressure in equation (10), and applying the chain
rule to the flux term, we can write:
∂m
∂t
=
∂
∂x
[
U (c,m)
∂m
∂x
− V (c,m)m ∂c
∂x
]
+ Sm (c,m) , (19)
where the effective, nonlinear diffusion coefficient is given by:
U (c,m) =
1
k
(1−m) Λ = 1
k
(1−m)
[
χ
1 + (κc)n
]
, (20)
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and the effective, nonlinear chemotaxis coefficient is:
V (c,m) = −1
k
(1−m) dΛ
dc
=
1
k
(1−m)
[
χnκncn−1
(1 + (κc)n)
2
]
. (21)
We emphasise here the dependence of the chemotaxis coefficient on c, which
implies that the overall chemotactic flux at any point in the domain will
depend not only on the local PDGF gradient, but also on the particular
local PDGF concentration.
Returning to the boundary conditions, we recall an earlier assumption in
the derivation of equation (12) that no SMCs will enter the lumen from the
intima. Therefore, we have the following condition:
1
k
(1−m) ∂
∂x
(mΛ) = 0 at x = 0
=⇒ ∂
∂x
(mΛ) = 0 at x = 0. (22)
At the medial boundary, we assume that a prior signalling cascade — most
likely involving MMPs — has allowed the resident (contractile) SMCs to de-
grade their local tissue and adopt a migratory (synthetic) phenotype (Newby
and Zaltsman, 1999). To invade the intima from the media, the SMCs must
first pass through the porous IEL, which is a dense tissue layer that separates
the intima from the media and provides a physical barrier to cell movement.
We therefore assume that migration of SMCs across this boundary is driven
entirely by chemotaxis to PDGF, and that the contribution from passive
diffusion is negligible. We introduce the parameter m∗ < 1 to represent
a constant synthetic SMC volume fraction in the media, and assume that
these SMCs enter the intima via a chemotactic response to the PDGF at the
boundary, so that:
1
k
(1−m) ∂
∂x
(mΛ) =
1
k
(1−m) dΛ
dc
m∗
∂c
∂x
at x = L
=⇒ ∂
∂x
(mΛ) =
dΛ
dc
m∗
∂c
∂x
at x = L. (23)
Note that the format of this boundary chemotactic flux is consistent with
the terms derived in equations (19) and (21), and also that this condition
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does not stipulate continuity of m across the boundary. A further conse-
quence of this boundary condition is that the influx of SMCs into our closed
system must be balanced by an equivalent efflux from the non-SMC phase.
Physically, we may interpret this efflux as a transfer of interstitial fluid to-
wards the medial tissue which has been locally degraded and vacated by
activated SMCs. This physical interpretation is inconsistent with the con-
tent of the non-SMC phase. We would not anticipate, for example, a net
efflux of macrophages out of the intima. However, we believe the model
remains reasonable provided that the overall intimal SMC population does
not become too large. Indeed, experimental measurements from mouse mod-
els indicate typical values of around just 10% for the total SMC content in
plaques (Mallat et al., 2001; Clarke et al., 2006). Alternative modelling ap-
proaches that specify additional phases and/or employ moving boundaries
could capture many features of plaque growth more naturally, but our aim
here is to develop a simple, foundational model of fibrous cap formation.
As mentioned earlier, we assume that the sole source of SMC-stimulating
PDGF is from an inward flux at the lumen. A number of cell types, including
macrophages and SMCs themselves, have been implicated in the production
of PDGF during plaque development (Libby and Ridker, 2006), but stim-
ulated endothelial cells and adherent platelets are believed to be the most
significant sources of the chemical (Funayama et al., 1998). We model this
with the following boundary condition:
Dc (1−m) ∂c
∂x
= −αc (1−m) at x = 0
=⇒ ∂c
∂x
= − αc
Dc
at x = 0, (24)
where, in the absence of SMCs at the lumen, αc represents a fixed rate of
PDGF flux into the intima. The term (1−m) is included to provide consis-
tency with the form of the nonlinear flux inside the domain; we note, however,
the inherent implication that the rate of PDGF supply to the intima will di-
minish with increasing SMC fraction at the boundary. This is consistent
with an assumption that SMCs inhibit, either in a direct or indirect manner,
the stimulation of endothelial cell PDGF production at the lumen.
Finally, we define a condition for the PDGF at the medial boundary.
Inspection of equation (23) indicates that in order for SMCs to migrate into
the intima from the media, a (negative) chemical gradient must exist at this
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point. To ensure the existence of such a gradient, we treat the IEL as a
porous membrane with permeability to PDGF denoted by σc, and assume a
diffusion-driven flux of chemical across the boundary:
Dc (1−m) ∂c
∂x
= σc (c
∗ − c) (1−m) at x = L
=⇒ ∂c
∂x
=
σc
Dc
(c∗ − c) at x = L. (25)
Here, c∗ represents a notional background PDGF concentration in the media,
and we again include a (1−m) term for consistency with the modulated flux
inside the domain.
Since the PDGF concentration is assumed to evolve in a quasi-steady
manner, an initial condition is not required to solve equation (18) and we
need only to define an initial SMC profile within the intima. In theory, this
profile should reflect the SMC population within healthy intimal tissue, which
is known to vary across species. Small populations of SMCs are believed
to reside in the intimal tissue of humans, pigs and primates; however, in
the majority of other animal models — most importantly in the genetically
modified mice used as an animal model to study plaque development — this
population is known to be completely absent (Newby and Zaltsman, 1999).
In this study we assume that the initial volume fraction of SMCs in the intima
is negligible. Since the model equations cannot support a domain entirely
devoid of SMCs (see the singularity arising in equation (16), for example),
we implement this assumption by assigning a small, uniform initial SMC
population:
m (x, 0) = mi, where 0 < mi  1. (26)
SMC Phase Source Terms
The full model comprises equations (17) and (18), subject to the boundary
and initial conditions stated in equations (22)-(26). The format of the generic
source term S in equation (17) remains to be determined.
Experimental studies have shown that SMCs proliferate throughout the
process of plaque formation (Lutgens et al., 1999). Rates of mitosis have
been reported to be exceedingly low (Gordon et al., 1990) but, over the long
timescale associated with disease progression, proliferation may still provide
a significant source of plaque SMCs (Newby and Zaltsman, 1999). In vitro
evidence has also indicated the upregulation of SMC mitosis in the presence
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of increasing PDGF concentration (Munro et al., 1994). Therefore, as well as
a linear rate of cell loss, our SMC source term includes logistic proliferation
with a growth factor-enhanced linear mitosis rate (Olsen et al., 1995):
Sm (c,m) = m (1−m)
(
rm0 + rm
[
c
cm + c
])
− βmm. (27)
Here, βm is the rate of cell loss, rm0 is the baseline mitosis rate, rm quantifies
the maximum possible PDGF-stimulated increase in the mitosis rate, and
cm represents the PDGF concentration where the half-maximal increase in
mitosis occurs.
Model Non-Dimensionalisation
Using tildes to denote dimensionless quantities, we rescale space x, time
t and PDGF concentration c as follows (note that the SMC volume fraction
m does not require rescaling):
x˜ =
x
L
, t˜ =
t
t0
, c˜ =
c
c0
, m˜ = m,
where t0 and c0 represent characteristic time and PDGF concentration values,
respectively. The model parameters can now be non-dimensionalised in the
following way:
χ˜ =
χt0
kL2
, κ˜ = κc0, r˜ = rm0t0, A˜ =
rm
rm0
, c˜m =
cm
c0
, β˜m = βmt0,
η˜c =
ηcL
2
Dc
, β˜c =
βcL
2
Dc
, α˜c =
αcL
Dcc0
, σ˜c =
σcL
Dc
, c˜∗ =
c∗
c0
.
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Dropping tildes for clarity, the corresponding dimensionless model equations,
boundary conditions and initial conditions are:
∂m
∂t
=
∂
∂x
[
(1−m) ∂
∂x
(mΛ)
]
+ rm (1−m)
(
1 +
Ac
cm + c
)
− βmm, (28)
∂
∂x
[
(1−m) ∂c
∂x
]
= ηccm (1−m) + βcc (1−m) , (29)
∂
∂x
(mΛ) = 0 at x = 0,
∂
∂x
(mΛ) =
dΛ
dc
m∗
∂c
∂x
at x = 1, (30)
∂c
∂x
= −αc at x = 0, ∂c
∂x
= σc (c
∗ − c) at x = 1, (31)
m (x, 0) = mi, (32)
wherein Λ (c) =
χ
1 + (κc)n
.
2.2. Model Parameterisation
The majority of our parameters have been informed by data from previ-
ous computational and experimental studies. When appropriate data could
not be obtained, we have selected values that ensure biologically reasonable
results. See Table 1 for the base case parameter set.
The progression of atherosclerosis is known to be slow, so we assume a
characteristic timescale of approximately 1 month by setting t0 = 2.5× 106 s.
The domain length L, which represents a typical intimal width at the time
SMC migration from the media is triggered, is chosen to be 75 µm (Grootaert
et al., 2015). Using cell trajectory data from in vitro experiments, Cai
et al. (2007) estimated the diffusion coefficient of fibroblasts to range from
5.0× 10−3 µm2 s−1 to 5.0× 10−2 µm2 s−1 depending on the extent of cell crow-
ding. To account for the influence of the macrophages and large foam cells
that also occupy the plaque tissue, we choose the SMC diffusion coefficient
near the middle of this range. The spatial and temporal scaling values give
the dimensionless motility coefficient χ = 4.
For the PDGF, we assume a characteristic physiological concentration
c0 = 10 ng ml
−1. This is consistent with estimates made by Olsen et al.
(1995) based on reported concentrations of PDGF storage in platelets (15–
50 ng ml−1; Huang et al. (1988)). Diffusion coefficient and decay rate values
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Parameter Description
Dimensionless
Reference
Value
n Exponent in SMC phase pres-
sure function
1.8 Schachter (1997)
κ Reciprocal of reference PDGF
concentration in SMC phase
pressure function
5.5 Schachter (1997)
χ SMC motility coefficient 4 Cai et al. (2007)
βm Rate of synthetic SMC loss 0.4 Lutgens et al. (1999)
η Rate of PDGF uptake by SMCs 1
βc Rate of PDGF decay 0.075 Haugh (2006)
αc Rate of PDGF influx from en-
dothelium
0.55
σc Permeability of IEL to PDGF 2
m∗ Volume fraction of synthetic
SMCs in media
0.01
r Baseline rate of SMC prolifera-
tion
0.02 Breton et al. (1986)
Lutgens et al. (1999)
c∗ PDGF concentration in media 0
A Maximal factor of PDGF-
stimulated increase in rate of
SMC proliferation
19 Munro et al. (1994)
cm PDGF concentration for half-
maximal increase in SMC pro-
liferation
1.4 Munro et al. (1994)
mi Initial SMC volume fraction in
intima
1.0× 10−4
Table 1: Base case parameter values. The final column highlights any references that have
been used to calculate individual parameter values. The values of parameters without
references have been chosen to ensure biologically reasonable results. Unless otherwise
stated, all reported simulations use these values.
from Haugh (2006) suggest a PDGF diffusion distance of around 300 µm.
In line with this, we set the dimensionless PDGF decay rate βc = 0.075.
Estimates for αc and σc are more difficult to obtain, so we select values that
give a reasonable initial profile of PDGF within the intima. Note that we
also set c∗ = 0, since the media is not known to provide a significant source
of PDGF.
The invasion of the intima by SMCs in our model is driven entirely by
the presence of a PDGF gradient. This migration ultimately depends on the
function Λ and its negated derivative −dΛ
dc
, which are proportional to the
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SMC diffusion and chemotaxis coefficients, respectively. Obtaining reason-
able estimates for the parameters κ and n is therefore crucial, and we do this
by using in vitro data on the chemotactic response of human vascular SMCs
to PDGF (Schachter (1997); see Figure 3). The experimental results pre-
dict maximal chemotaxis at a PDGF concentration around 1 ng ml−1, with
a gradual drop-off for lower PDGF levels and a sharper drop-off for higher
PDGF levels. By setting κ = 5.5 and n = 1.8, we obtain a prediction for the
form of Λ and an excellent fit for −dΛ
dc
.
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Figure 3: Responses of SMCs across a range of PDGF concentrations in the model (solid
lines) and from in vitro experiments (data points). The blue line, which corresponds to
the SMC phase pressure function Λ (c) (see equation (10)), shows the variation in the
normalised SMC diffusion coefficient with PDGF concentration. The red line, which cor-
responds to −dΛdc , shows the variation in the normalised SMC chemotaxis coefficient with
PDGF concentration. The function Λ (c) has been parameterised to fit the experimental
data on SMC chemotaxis (red squares) using parameter values n = 1.8 and κ = 5.5. The
gold line shows the normalised variation in SMC proliferation with PDGF concentration,
and has been fitted to the experimental data (gold circles) using a simple functional form
(see equation (28)) with parameter values A = 19 and cm = 1.4. Proliferation data was
obtained from Munro et al. (1994) and chemotaxis data was obtained from Schachter
(1997).
Using further experimental data, we also obtain estimates for the param-
eters in the SMC source terms. In vitro measurements from Munro et al.
(1994) on the proliferative response of SMCs to PDGF are plotted in Fig-
ure 3. Fitting these to our PDGF-enhanced mitosis function suggests the
parameter values A = 19 and cm = 1.4. For PDGF concentrations in the
physiologically realistic range (i.e. around 10 ng ml−1 and below), this simple
functional form provides a good fit to the experimental data.
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The parameters A and cm define the manner in which PDGF stimulates
SMC division in the model, but not the actual rate of proliferation. To esti-
mate this rate in the intima during fibrous cap development we look instead
to in vivo measurements. Proliferative indices for cells (i.e. the observed
fraction of cells undergoing mitosis at a fixed time point) in advanced hu-
man atherosclerotic plaques have been calculated to be no more than 1%
(Gordon et al., 1990; Lutgens et al., 1999). Taking a typical SMC doubling
time to be 32 hours (Breton et al., 1986), and adjusting downwards for po-
tential PDGF-stimulated proliferation in these measured indices, we assume
a baseline proliferation rate r = 0.02. Lutgens et al. (1999) also identified
apoptotic indices in advanced plaques to be around 1%. Since cell apoptosis
is likely to be much quicker than cell division, we assume the rate of SMC
death to be at least an order of magnitude higher than that for proliferation
and set βm = 0.4.
3. Results
Numerical results using the base case set of parameter values are pre-
sented below, followed by a number of sensitivity studies that provide ad-
ditional insight into the cap formation process. We re-iterate here that we
do not explicitly model the formation of the cap, but rather investigate the
population dynamics of the collagen-synthesising SMCs. Our model is rele-
vant during the early stages of fibrous cap formation, before the endothelium
becomes overly distended by plaque growth and protrudes into the lumen.
By comparing SMC volume fraction distributions in the intima under differ-
ent parameter regimes, we use the model to assess the likely implications for
fibrous cap stability.
3.1. Base Case Simulation
The initial SMC response to the PDGF profile in the base case simulation
is shown in Figure 4: cells emerge from the media, migrate across the intima
and begin to accumulate at the luminal boundary. SMCs continue to enter
the intima over time, and an identifiable cap region, which displays a signif-
icantly elevated cell volume fraction, appears near the lumen after around
4–6 months (Figure 5a). This timescale shows excellent correlation with the
work of Kozaki et al. (2002), who observed the development of fibrous caps in
mice over periods of around 25 weeks. The increase in plaque SMC content,
particularly near the lumen, reduces PDGF diffusion and increases uptake of
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PDGF. The PDGF gradient at the medial boundary also falls (Figure 5b),
and the rate of recruitment of new cells is gradually reduced. SMCs con-
tinue to accumulate slowly, however, and the cell profile finally reaches a
steady-state after around 15 months (Figure 5a). The total SMC content
in the simulated plaque at this time is approximately 11.2%, which is con-
sistent with experimental data from studies using the atherosclerosis-prone
apolipoprotein E (ApoE) knockout mouse (Mallat et al., 2001; Clarke et al.,
2006).
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Figure 4: SMC volume fraction distributions in the intima at an early stage of cap de-
velopment in the base case simulation. The initial SMC volume fraction in the intima
is small and uniform (m (x, 0) = 1 × 10−4). SMCs enter the domain in response to the
PDGF concentration gradient at the medial boundary (x = 1) and migrate towards the
PDGF source at the endothelium (x = 0). The arrow indicates the direction of sequential
time points, which correspond to t = 0.2, 0.4, 0.6, 0.8 and 1.
The above simulation demonstrates a dynamic interplay between the
media-derived SMCs and the endothelium-derived PDGF that leads the SMC
population to evolve naturally towards a profile that resembles a fibrous cap
in the intima. Cap formation in the model arises from a highly nonlinear
balance between SMC recruitment from the media, chemotactic migration
towards the lumen and cell turnover through proliferation and apoptosis.
However, the relative contribution of each of these factors, and their impor-
tance in determining overall cap stability, cannot be assessed from any single
simulation. We therefore investigate each of these mechanisms in greater
detail below by performing sensitivity simulations on a number of key model
parameters.
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Figure 5: (a) SMC volume fraction and (b) PDGF concentration distributions in the
intima throughout cap development in the base case simulation. SMC accumulation in
the intima depletes the intimal PDGF due to increased PDGF uptake and reduced PDGF
influx at the endothelium. The arrows indicate the direction of sequential time points,
which correspond to t = 0.6, 1.4, 2.6, 4.6 and 15. At the final time point, both variables
have reached a steady-state.
3.2. Sensitivity Analysis
SMC Kinetics
The formation of the fibrous cap requires the accumulation of matrix-
synthesising SMCs near the endothelial lining of the arterial wall. Invasion
from the media and proliferation within the intima are the two primary
sources of these cells, but the extent to which each of these factors con-
tributes to cap formation is unknown. Figure 6 compares the steady-state
SMC profile from the base case with that from a simulation with no cell pro-
liferation (i.e. r = 0). As expected, proliferation contributes most strongly
near the lumen where PDGF-stimulated cell division is largest. Overall, how-
ever, proliferation provides less than one quarter of the total SMC volume
fraction in the base case simulation, and three quarters of the SMCs have
migrated from the media. These results yield two interesting conclusions
about fibrous cap synthesis. First, while SMC proliferation in the intima
may enhance the thickness of a nascent cap, it does not appear to be neces-
sary for cap formation. Second, the relative balance between SMC loss and
SMC recruitment from the media (through the parameters βm and m
∗, re-
spectively) is likely to be a key factor in the ability of SMCs to form a stable
cap. Sensitivity simulations on βm and m
∗ support this latter conclusion,
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and also highlight that reducing SMC loss (i.e. reducing βm) is a more effec-
tive way to increase SMC numbers in the cap region compared to increasing
SMC recruitment (i.e. increasing m∗). This is because a reduction in SMC
loss leads to a greater contribution from SMC proliferation, particularly near
the endothelium where the PDGF signal is strong.
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Figure 6: Steady-state SMC volume fraction distributions in the intima for the base case
simulation (solid line) and a simulation with no SMC proliferation (r = 0; dashed line).
Both plots are taken at time t = 24.
SMC Motility
In our model, the recruitment of SMCs from the media and their sub-
sequent migration across the intima is driven entirely by the PDGF profile.
Therefore, it is important to study the parameters that control this migra-
tory response and to determine the effect of SMC migration on cap forma-
tion. We investigate the impact of changing the exponent n in the SMC
phase pressure function Λ (c), since this function provides an explicit link
between SMC movement and the evolving chemical profile. We vary this
parameter both upwards and downwards, choosing n = 1 and n = 2.6. The
effect of these variations for both Λ (i.e. diffusion) and −dΛ
dc
(i.e. chemotaxis)
are plotted in Figure 7, and we emphasise here that the relevant range for di-
mensionless PDGF concentration during a typical simulation is around 0.1–1
(i.e. 1–10 ng ml−1). In this range, the plots suggest that the general bal-
ance of the respective SMC flux terms should be tipped towards diffusion for
n = 1 and towards chemotaxis for n = 2.6. This finding is confirmed by the
steady-state SMC distributions for these scenarios (Figure 8). For n = 1, the
model predicts a vast reduction in cell recruitment that leads to a shallow
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SMC profile with a barely discernible cap region. Alternatively, for n = 2.6,
the model yields a highly nonlinear SMC profile that potentially provides a
stronger and more stable cap than the base case simulation. Interestingly,
the overall SMC response is also much more efficient for n = 2.6, reaching
the improved steady-state profile in less than 12 months.
Figure 7: Sensitivity of the PDGF-dependent SMC diffusion (dashed lines) and chemo-
taxis (solid lines) coefficients to changes in the parameter n in the SMC phase pressure
function Λ (c) (see equation (10)). Diffusion coefficients correspond to Λ (c) and chemo-
taxis coefficients correspond to −dΛdc . The base case coefficients are shown in dark blue,
coefficients for a reduced value (n = 1) are shown in red, and coefficients for an increased
value (n = 2.6) are shown in magenta.
For completeness we briefly discuss our observations from varying the
value of κ in Λ (c), although we do not present any results. Simulations
indicate that the level of SMC recruitment to the cap region has a bipha-
sic dependence on κ, where the maximum level of SMC recruitment occurs
around the base case value (κ = 5.5). In contrast to the results presented for
n, cap formation appears to be relatively insensitive to changes in the value
of κ. Values of κ in the range 3.5 to 7.5, for example, produce only minor
changes to the final steady-state SMC profiles. As κ diverges from this range,
cap formation is increasingly hampered, and, in the case of large κ values,
we note a significant reduction in the rate of formation of the compromised
caps. This appears to be due to a combination of reduced SMC invasion
from the media and a reduced rate of migration across the intima.
PDGF Profile
In addition to manipulating the SMC response to PDGF, it is also of
interest to explore the parameters controlling the evolution of the chemical
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Figure 8: Simulation results showing how the steady-state SMC volume fraction distribu-
tions in the intima depend on the parameter n in the SMC phase pressure function Λ (c)
(see equation (10)). Results from the base case simulation (solid line) are compared to
results for a decrease (n = 1; dot-dash line) and an increase (n = 2.6; dashed line) in the
value of n. All plots are taken at time t = 24.
profile itself. We consider the consequences of varying αc, which represents
the rate of PDGF flux into the intima. We choose the values αc = 0.35 and
αc = 0.75, and compare the initial PDGF profiles for these two scenarios
and the base case (αc = 0.55) in Figure 9. For αc = 0.35 both the concen-
tration and the gradient of PDGF is reduced throughout the intima, while
for αc = 0.75 both the concentration and the gradient of PDGF is increased
throughout the intima. Note that these parameter values have been chosen
to ensure that the chemical concentrations and gradients in the narrow in-
tima remain within reasonable bounds. The SMC responses that result from
these PDGF profiles are presented in Figure 10: the final steady-state SMC
distributions are given in Figure 10a, while the overall SMC volume fractions
in the intima (i.e.
∫ 1
0
m (x, t) dx) are plotted against time in Figure 10b. As
would be expected, decreasing the production of PDGF at the lumen re-
duces the recruitment of SMCs from the media and reduces the potential for
cap formation. Given the relatively low chemical gradient across the intima,
however, the observed cellular response in this case is quick and remarkably
robust. It appears likely that this is due to the pronounced peak in the
chemotactic coefficient that occurs around dimensionless PDGF concentra-
tions of 0.1 (i.e. 1 ng ml−1; c.f. Figure 3). This result contrasts strongly with
the case where the influx of PDGF is increased. Despite the relatively steep
PDGF gradient and the enhanced potential for SMC proliferation, this sim-
ulation predicts the slowest rate of SMC recruitment. Indeed, for αc = 0.75
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the total cell content in the intima lags behind that in the case with αc = 0.35
for the first 7–8 months of the simulation. Moreover, increasing the value of
αc ultimately results in a cap that is less stable than the one generated in
the base case. These results suggest that stimulating PDGF production has
the potential to inhibit the SMC chemotactic response and thereby reduce
both the efficiency and the efficacy of fibrous cap formation.
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Figure 9: Simulation results showing how the initial PDGF concentration distribution in
the intima changes as we vary the rate of PDGF influx from the endothelium αc. The
initial PDGF profile for the base case simulation (solid lines) is compared to those for a
decrease (αc = 0.35; dot-dash line) and an increase (αc = 0.75; dashed line) in the value
of αc.
4. Discussion
In atherosclerosis, a protective fibrous cap is formed when SMCs are re-
cruited from the media to synthesise new ECM and repair the damage caused
by excessive accumulation of lipoproteins and inflammatory cells. The de-
velopment of a stable fibrous cap is a key determinant of the prognosis for
this disease, but the mechanisms of cap formation remain poorly understood.
In this paper, we have formulated a multiphase model to investigate initial
fibrous cap growth and identify key parameters that may contribute to cap
stability. This work represents the first attempt to investigate fibrous cap
formation in atherosclerosis using mathematical modelling. A key assump-
tion of our approach has been to focus on SMCs only and not explicitly
model collagen deposition. We have therefore modelled the dynamics of the
collagen-synthesising SMC population, and assumed that the underlying ma-
trix will evolve to broadly reflect the SMC profile in the diseased intima. This
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Figure 10: Simulation results showing how the SMC response changes as we vary the
rate of PDGF influx from the endothelium αc. The plots show (a) the final steady-state
SMC volume fraction distribution in the intima and (b) the variation of the total SMC
volume fraction in the intima over time for each simulation. Results from the base case
simulation (solid lines) are compared to results for a decrease (αc = 0.35; dot-dash line)
and an increase (αc = 0.75; dashed line) in the value of αc. The steady-state plots are
taken at time t = 24.
assumption has allowed us to derive a two-phase model that focusses on the
chemotactic response of SMCs to endothelium-derived PDGF. We have used
a variety of in vivo, in vitro and in silico studies to obtain accurate estimates
for key parameters in our model, and we have made assumptions that are
consistent with observations of fibrous cap formation in the mouse. In our
base case simulation, we have shown that both the timescale of cap formation
and the total SMC volume fraction in the plaque are consistent with results
from experiments using the atherosclerosis-prone ApoE knockout mouse.
The approach that we have taken in this paper has some limitations. For
example, we have not explicitly considered the remodelling of the intimal
tissue undertaken by SMCs recruited to in vivo plaques. During cap forma-
tion, the initial elastin and proteoglycan matrix in the intima is degraded by
SMCs and replaced by a new matrix primarily composed of fibrillar collagen.
A range of in vivo and in vitro studies have suggested that haptotaxis in
response to collagen — as well as chemotaxis in response to growth factors
such as PDGF — may be an important mechanism of SMC migration in
plaques (Nelson et al., 1996; Lopes et al., 2013). We have neglected this
effect in the current study because we anticipate SMC chemotaxis will be
the primary driver of fibrous cap formation, but in future studies we will
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investigate ECM remodelling in the plaque and the consequent impact of
haptotaxis on SMC migration. Our fibrous cap model also does not include
the inflammatory dynamics that take place in the plaque. Chronic plaque in-
flammation involves the sustained infiltration of lipoproteins and monocytes
from the bloodstream, and the accumulation of fats and cellular debris in the
intima. This process causes expansion of the intima during plaque develop-
ment, and the implication is that fibrous cap growth may take place within
tissue undergoing gradual expansion. We believe, however, that our fixed do-
main simulations of cap growth provide a reasonable initial approximation.
More detailed approaches will be required to develop realistic coupled mod-
els of plaque inflammation and fibrous cap formation during atherosclerotic
plaque growth.
Development of the fibrous cap (and the atherosclerotic plaque, in gen-
eral) provides an intrinsically difficult challenge for mathematical modelling.
The cap (or plaque) grows in the arterial intima, but much of this growth is
driven by events that occur beyond this tissue layer. In the current context,
for example, we have studied the activation and migration of medial SMCs
in response to a PDGF signal generated at the endothelium. Our modelling
domain represents only the narrow intima inside the artery wall, so the phe-
nomena that occur at the endothelium and in the media have been captured
by a set of non-standard boundary conditions.
For SMCs, the boundary condition imposed at the medial end of the
domain (i.e. x = 1) is crucial. Although the model does include a SMC
proliferation term, most of the intimal SMCs are derived from the media
and the model predicts no cap formation in the absence of this source. We
have assumed that synthetic medial SMCs migrate through the IEL into the
intima in an active (i.e. chemotactic) rather than a passive (i.e. diffusive)
fashion. This assumption leads us to introduce the parameter m∗, which
notionally represents a constant synthetic medial SMC volume fraction. In
effect, however, m∗ implicitly quantifies a number of factors that we do not
explicitly model, such as the rate of contractile to synthetic SMC transition
and the rate of SMC migration in the medial tissue. Note that our mod-
elling predicts the value of m∗ to be particularly low (i.e. m∗ = 0.01 for the
base case simulation). This suggests that SMC recruitment from the me-
dia is likely to be a rate-limiting factor in fibrous cap development, which
may reflect a physiological need to limit the depletion of SMCs in the me-
dia. The proliferation rate of SMCs in the media is believed to remain at
low, non-diseased rates throughout atherosclerosis (Lutgens et al., 1999), so
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widespread SMC depletion in the media could ultimately have an adverse
impact on cap stability.
In our model, the recruitment of SMCs from the media to form the fibrous
cap is reliant upon a gradient of PDGF. In the absence of a PDGF gradient
at the medial boundary, no SMCs will enter the domain from the media and
a cap of SMCs at the endothelium will not be formed. We assume there is a
flux of PDGF into the intima from the damaged endothelium (i.e. at x = 0),
and that a gradient of PDGF at the medial boundary is created by outward
diffusion of PDGF into the media through the porous IEL. The width of the
domain on which we solve our equations (75µm) is relatively small compared
to the PDGF diffusion distance (300 µm). The model therefore typically
predicts PDGF profiles that are approximately linear with significant loss of
PDGF to the media. This is reasonable provided we assume, for example,
that SMCs in the media uptake significant PDGF. In general, however, it is
likely that our intimal PDGF profiles may not be as well-developed as they
would be on a larger domain. This factor was taken into account when we
made our parameter selections, and we have only considered PDGF profiles
that demonstrate biologically reasonable gradients and concentrations. We
will address this limitation in future studies by developing models on larger
domains that include both the intima and the media, but we do not anticipate
any significant changes to the broad conclusions of the current work.
The intimal SMC profiles generated by our model are the result of a dy-
namic combination of SMC diffusion, chemotaxis and proliferation — all of
which depend nonlinearly on the PDGF concentration. For both chemotaxis
and proliferation, the model responses have been informed by in vitro mea-
surements on vascular SMCs. SMC chemotaxis shows a biphasic response
to PDGF across a range of intermediate PDGF concentrations. SMC pro-
liferation, on the other hand, tends to occur at larger PDGF concentrations
where the chemotactic sensitivity is significantly diminished. This pattern
of SMC behaviour is consistent with current understanding of fibrous cap
formation: PDGF produced at the damaged endothelium recruits SMCs by
chemotaxis from the distal media and then stimulates their proliferation to
enhance matrix synthesis and tissue stability proximal to the cap region.
Our simulations are consistent with this theory, but they have also identified
several parameters that can influence the effectiveness of the cap formation
process.
A key model prediction is that the influence of SMC proliferation ap-
pears to be relatively small during cap formation. At steady-state in the
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base case simulation, for example, we identified that only 25% of the SMCs
in the cap region could be attributed to mitosis, while the remaining 75%
had been recruited from the media. Although the rates of SMC prolifera-
tion in our simulations are rather low (doubling times range from about 3
months to 18 months depending on the local PDGF concentration), the lim-
ited contribution from proliferating cells also appears to be a consequence of
the narrow width of the intima. Across this thin tissue region, we can only
expect relatively shallow PDGF gradients. As a result, the PDGF concen-
tration in the cap region is generally similar to that at the medial boundary.
Where these PDGF concentrations are low enough to favour chemotactic
SMC recruitment from the media, proliferation rates in the cap region are
suppressed. Alternatively, where the PDGF concentrations are high enough
to favour proliferation, SMC recruitment is reduced and so is the pool of cells
available for division. Of course, these results are based on the assumption of
fixed PDGF influx from the endothelium. If PDGF production was gradually
increased over time, for example, we may observe significant SMC migration
to the cap region at low PDGF followed by significant SMC proliferation at
high PDGF, ultimately leading to enhanced cap stability. These ideas raise
interesting questions as to how the balance between SMC migration and
proliferation may evolve as the intima expands during long-term plaque de-
velopment, and also how this balance may translate to human atherosclerosis
where the intima is typically much wider than in the mouse.
As a consequence of the limited potential for SMC mitosis in our model,
the dynamic balance between between SMC recruitment from the media
(controlled by m∗) and SMC loss within the plaque (controlled by βm) be-
comes critical to the formation of a stable fibrous cap. The rate of SMC
migration (controlled by the cell motility coefficient χ) is also important to
cap formation, but note that the impact of an increase in the migration rate
would be limited if medial SMCs were in short supply (i.e. for very small
m∗). We have not presented the results here, but our simulations indicate
that the total SMC content in the intima is strongly sensitive to variations
in the values of both βm and m
∗. In the particular case of an increase in βm,
we observe reduced SMC numbers in the cap region and anticipate that this
would adversely affect cap stability. This interpretation is consistent with
the experimental results of Clarke et al. (2006). By developing a transgenic
mouse in which plaque SMCs could be induced to undergo apoptosis by treat-
ment with diphtheria toxin, Clarke et al. (2006) found that reduced plaque
collagen content and reduced fibrous cap thickness were direct consequences
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of elevated SMC death.
The dynamic balance between SMC diffusion and chemotaxis may also
play a crucial role in the fibrous cap formation process. Within the frame-
work of our model, these two forms of cell movement are highly nonlinear and
intrinsically linked by the SMC phase pressure function Λ (c). The SMC diffu-
sion coefficient is directly proportional to Λ itself, while the SMC chemotaxis
coefficient is instead proportional to −dΛ
dc
. The function Λ (c) is characterised
by the parameters n and κ, and both of these influence the SMC response
to PDGF signalling. In terms of SMC recruitment to the cap region, our
simulations were insensitive to κ across a range of values from 3.5 to 7.5.
The exponent n, on the other hand, had a dramatic impact on SMC cap
formation. Within the relevant range of PDGF concentration, decreasing n
decreases the chemotaxis coefficient and increases the diffusion coefficient,
while increasing n has the opposite effect. Consequently, a simulation with
reduced n produced a shallow SMC profile that lacked a discernible cap re-
gion, while a simulation with increased n produced a steep SMC profile with
an enhanced SMC volume fraction in the cap region. These features of the
SMC profile in the large n simulation are highly desirable in the context of
plaque stability. The results in this case display an abundance of SMCs near
the endothelium and relatively few beyond, which implies that the plaque
will form a dense, protective cap region without excessive hardening of the
remainder of the artery. These results highlight the importance of a strong
SMC chemotactic response during fibrous cap formation.
The evolution of PDGF concentration in our simulations is influenced by
factors that include the uptake of PDGF by migrating SMCs and modulated
diffusive transport of PDGF due to SMC accumulation near the endothe-
lium. However, the PDGF profile in the intima is primarily determined by
the influx and efflux of PDGF, which depend on the parameters αc and
σc, respectively. Sensitivity simulations for αc produce surprising results.
Steady-state SMC profiles were found to be relatively insensitive to αc val-
ues between 0.35 and 0.75, despite a greater than two-fold increase in the
intimal PDGF gradient over this range. Moreover, the steepest PDGF gra-
dient yielded the slowest rate of cap formation. This result reflects the fact
that an increase in the chemical gradient was associated with a concurrent
increase in the PDGF concentration levels throughout the domain. The ele-
vated PDGF levels significantly reduced the chemotactic sensitivity of SMCs
to PDGF, and this slowed cap formation by reducing both the rate of SMC
recruitment from the media and the rate of SMC migration in the intima.
31
The fact that our model can predict the formation of stable fibrous caps over
a range of timescales is significant because it reflects the wide variation in
the observed times required for thick cap formation in experimental studies
(Kozaki et al., 2002). These results indicate that, while a gradient of PDGF
in the intima is necessary for cap formation, the stability of the fibrous cap
and the rate of cap formation may depend critically upon the maintenance
of appropriate PDGF concentration levels.
In the biomedical literature there is a prevailing view that a growing
atherosclerotic plaque will establish an initially strong fibrous cap, but plaque
rupture may ultimately be induced by a gradual thinning or erosion of the
cap over time. It is important to emphasise that the model presented in this
paper focusses purely on the early process of cap establishment, and does
not include factors that may become relevant for long-term cap maintenance.
Mechanisms of fibrous cap erosion are poorly understood, but a number of
factors — many of which can be linked to plaque inflammation — have
been proposed. These include excessive matrix degradation by macrophage-
produced MMPs (Lusis, 2000) and reduced SMC matrix production due to a
phenotypic change that has been linked to excessive lipoprotein consumption
by SMCs in plaques (Bennett et al., 2016). Plaque rupture due to fibrous cap
thinning is known to be a pre-cursor to heart attacks and strokes. Modelling
mechanisms of cap erosion will be a key target for future studies.
In this work we have developed a multiphase model to investigate the re-
sponse of medial SMCs to endothelium-derived PDGF signalling in atheroscl-
erotic plaques. Our model predicts that SMCs will accumulate near the en-
dothelium and form fibrous caps for a wide range of parameter sets, but also
that variations in key parameters can lead to changes in cap thickness. In
particular, we have found cap thickness to be particularly sensitive to the
balance between SMC apoptosis and SMC recruitment from the media, as
well as to the balance between SMC diffusion and SMC chemotaxis. We
have also demonstrated that the rate of cap formation can be highly vari-
able, and that stable caps can form over a wide range of time scales. This
study represents the foundation of a mechanistic modelling framework that
can be readily extended to further investigate mechanisms of cap formation
and atherosclerotic plaque development in general.
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